These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 21163543)

  • 1. From maturity to value-added innovation: lessons from the pharmaceutical and agro-biotechnology industries.
    Mittra J; Tait J; Wield D
    Trends Biotechnol; 2011 Mar; 29(3):105-9. PubMed ID: 21163543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innovation in biotechnology: current and future states.
    Woollett GR
    Clin Pharmacol Ther; 2012 Jan; 91(1):17-20. PubMed ID: 22179626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Financial Times Global Pharmaceutical & Biotechnology Conference 2009.
    Scattereggia J
    IDrugs; 2010 Jan; 13(1):26-9. PubMed ID: 20024844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How changes in drug-safety regulations affect the way drug and biotech companies invest in innovation.
    Reed SD; Califf RM; Schulman KA
    Health Aff (Millwood); 2006; 25(5):1309-17. PubMed ID: 16966727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overcoming the obstacles in the pharma/biotech industry: 2008 update.
    Graul AI; Revel L; Rosa E; Cruces E
    Drug News Perspect; 2009; 22(1):39-51. PubMed ID: 19209298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biotech as Bush bows out.
    Lorenzo A
    Nat Biotechnol; 2008 Jan; 26(1):15-8. PubMed ID: 18183006
    [No Abstract]   [Full Text] [Related]  

  • 7. The Indian and Chinese health biotechnology industries: potential champions of global health?
    Frew SE; Kettler HE; Singer PA
    Health Aff (Millwood); 2008; 27(4):1029-41. PubMed ID: 18607038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of biotechnology products in the global pharmaceutical market: the case of the European community and the United States.
    Hakim Z; Kucukarslan S
    Clin Ther; 1993; 15(2):442-58; discussion 432. PubMed ID: 8519050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Europe caught in innovation quagmire.
    Mitchell P
    Nat Biotechnol; 2005 Sep; 23(9):1029. PubMed ID: 16151378
    [No Abstract]   [Full Text] [Related]  

  • 10. The changing environment for technological innovation in health care.
    Goodman CS; Gelijns AC
    Baxter Health Policy Rev; 1996; 2():267-315. PubMed ID: 11066263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overcoming further challenges in the pharma/biotech industry: 2007 update.
    Graul AI; Cruces E; Revel L; Serradell N; Rosa E
    Drug News Perspect; 2008; 21(1):44-58. PubMed ID: 18301809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic patent protection in the pharmaceutical and biotechnology industries.
    Nunnally AC; Webster CJ; Brown SA; Cohen GA
    Community Genet; 2005; 8(4):209-16. PubMed ID: 16244474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retail price regulation and innovation: reference pricing in the pharmaceutical industry.
    Bardey D; Bommier A; Jullien B
    J Health Econ; 2010 Mar; 29(2):303-16. PubMed ID: 20053474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Industry and regulatory performance in 2012: a year in review.
    Dowden HM; Jahn R; Catka T; Jonsson A; Michael E; Miwa Y; Zinkand W
    Clin Pharmacol Ther; 2013 Sep; 94(3):359-66. PubMed ID: 23657160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The patentability of antibodies in the United States.
    Lu DL; Collison AM; Kowalski TJ
    Nat Biotechnol; 2005 Sep; 23(9):1079-80. PubMed ID: 16151395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Manufacturing, regulatory and commercial challenges of biopharmaceuticals production: a Finnish perspective.
    Närhi M; Nordström K
    Eur J Pharm Biopharm; 2005 Apr; 59(3):397-405. PubMed ID: 15760720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overcoming the challenges in the pharma/biotech industry.
    Graul AI; Prous JR
    Drug News Perspect; 2007; 20(1):57-68. PubMed ID: 17332900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmaceutical R&D performance by firm size: approval success rates and economic returns.
    DiMasi JA
    Am J Ther; 2014; 21(1):26-34. PubMed ID: 23344103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pipelines turn to biotech.
    Lawrence S
    Nat Biotechnol; 2007 Dec; 25(12):1342. PubMed ID: 18066015
    [No Abstract]   [Full Text] [Related]  

  • 20. Innovation in biotechnology: moving from academic research to product development--the case of biosensors.
    Siontorou CG; Batzias FA
    Crit Rev Biotechnol; 2010 Jun; 30(2):79-98. PubMed ID: 20214418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.